Annals of Surgical Oncology, Vol 7, Issue 2 98-105, Copyright © 2000 by Society of Surgical Oncology

ARTICLES

Active macromolecule uptake by lymph node antigen-presenting cells: a novel mechanism in determining sentinel lymph node status

M. B. Faries, I. Bedrosian, C. Reynolds, H. Q. Nguyen, A. Alavi and B. J. Czerniecki
Department of Surgery, University of Pennsylvania, Philadelphia, USA.

BACKGROUND: Although sentinel lymph node (SLN) biopsy is a powerful staging tool for patients with melanoma and breast cancer, controversy remains regarding specific aspects of technique. We examined particle uptake by antigen-presenting cells (APCs) to determine if this mechanism is responsible for the differential retention of radioactivity in SLNs relative to nonsentinel lymph nodes (NSLNs). METHODS: Mapping was conducted in pigs injected with vital blue dye, fluoroscein isothiocyanate-labeled human serum albumin (FITC-HSA), and one of two 99mtechnetium-labeled tracers, i.e., human serum albumin, a small macromolecule, or unfiltered sulfur colloid, a mixture of small and large particles. Macromolecule uptake by APCs was studied in vitro by using FITC-HSA and measured by fluorescence-activated cell sorting (FACS). SLNs and NSLNs were analyzed by fluorescence microscopy or FACS, with counterstaining for leukocyte cell surface markers. RESULTS: Both radiotracers were effective. Cultured APCs rapidly took up FITC-HSA. Microscopy showed FITC-HSA in the subcapsular sinus of SLNs shortly after injection and subsequent distribution to interfollicular areas. FACS revealed increasing amounts of FITC-HSA in SLNs over time. Cells responsible for uptake were APCs, expressing major histocompatibility (locus) class II. CONCLUSIONS: This report establishes active macromolecule uptake as a mechanism that determines SLN status. This mechanism has important implications for performing SLN biopsy.

This article has been cited by other articles:

				J. A. Sanchez-Brunete, M. A. Dea, S. Rama, F. Bolas, J. M. Alunda, R. Raposo, M. T. Mendez, S. Torrado-Santiago, and J. J. Torrado Treatment of Experimental Visceral Leishmaniasis with Amphotericin B in Stable Albumin Microspheres Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3246 - 3252. [Abstract] [Full Text] [PDF]

				G. D'Eredita', F. Ferrarese, V. Cecere, S. T. Massa, F. de Carne, and G. Fabiano Subareolar Injection May Be More Accurate Than Other Techniques for Sentinel Lymph Node Biopsy in Breast Cancer Ann. Surg. Oncol., October 1, 2003; 10(8): 942 - 947. [Abstract] [Full Text] [PDF]

				G. W. Carlson, D. R. Murray, V. Thourani, A. Hestley, and C. Cohen The Definition of the Sentinel Lymph Node in Melanoma Based on Radioactive Counts Ann. Surg. Oncol., November 1, 2002; 9(9): 929 - 933. [Abstract] [Full Text] [PDF]

				T. W. Bauer, F. R. Spitz, L. S. Callans, A. Alavi, R. Mick, S. P. Weinstein, I. Bedrosian, D. L. Fraker, T. L. Bauer, and B. J. Czerniecki Subareolar and Peritumoral Injection Identify Similar Sentinel Nodes for Breast Cancer Ann. Surg. Oncol., March 1, 2002; 9(2): 169 - 176. [Abstract] [Full Text] [PDF]